posted on 2022-01-26, 20:37authored byRadhika Sharma, Yixiao Dong, Yuesong Hu, Victor Pui-Yan Ma, Khalid Salaita
Delivery
of nucleic acids can be hindered by multiple factors including
nuclease susceptibility, endosome trapping, and clearance. Multiple
nanotechnology scaffolds have offered promising solutions, and among
these, lipid-based systems are advantageous because of their high
biocompatibility and low toxicity. However, many lipid nanoparticle
systems still have issues regarding stability, rapid clearance, and
cargo leakage. Herein, we demonstrate the use of a synthetic nanodisc
(ND) scaffold functionalized with an anti-HIF-1-α antisense
oligonucleotide (ASO) to reduce HIF-1-α mRNA transcript levels.
We prepared ND conjugates by using a mixture of phosphoglycerolipids
with phosphocholine and phosphothioethanol headgroups that self-assemble
into a ∼13 × 5 nm discoidal structure upon addition of
a 22-amino-acid ApoA1 mimetic peptide. Optimized reaction conditions
yield 15 copies of the anti-HIF-1-α ASO DNA covalently conjugated
to the thiolated phospholipids using maleimide–thiol chemistry.
We show that DNA-ND conjugates are active, nuclease resistant, and
rapidly internalized into cells to regulate HIF-1-α mRNA levels
without the use of transfection agents. DNA-ND uptake is partially
mediated through Scavenger Receptor B1 and the ND conjugates show
enhanced knockdown of HIF-1-α compared to that of the soluble
ASOs in multiple cell lines. Our results demonstrate that covalently
functionalized NDs may offer an improved platform for ASO therapeutics.